The table below summarizes the most recent Jasper Therapeutics insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Jasper Therapeutics insider buys are important for investors to follow.

Date	Insider	Price	Amount
2-8-2024 Insider Buy	Carlyle Group Inc.	$12.95 CAGR »	$2,460,500.00 190,000 shares
2-8-2024 Insider Buy	Capital Investment Management LP Velan >10% Owner	$12.95 CAGR »	$4,532,500.00 350,000 shares
11-28-2023 Insider Buy	Thomas G. Wiggans Director	$0.65 CAGR »	$6,486.00 10,000 shares
11-21-2023 Insider Buy	Thomas G. Wiggans Director	$0.64 CAGR »	$6,383.00 10,000 shares
11-20-2023 Insider Buy	Thomas G. Wiggans Director	$0.61 CAGR »	$18,240.00 30,000 shares
1-27-2023 Insider Buy	Qiming U.S. Healthcare Fund II, L.P. >10% Owner	$1.50 CAGR »	$3,999,999.00 2,666,666 shares
1-27-2023 Insider Buy	Carlyle Group Inc. >10% Owner	$1.50 CAGR »	$4,699,999.50 3,133,333 shares

Also See: Institutional Holders of JSPR
Also See: SEC filings

Below we present the annualized performance delivered by Jasper Therapeutics stock since 2-8-2024 (the date of the most recent insider purchase). The performance of the investment from the time Jasper Therapeutics insider buying occurred is the ultimate test of whether insiders were right about JSPR being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	02/09/2024
End date:	04/26/2024
Start price/share:	$17.59
End price/share:	$20.40
Dividends collected/share:	$0.00
Total return:	15.97%
Annualized Gain:	76.72%
Starting investment:	$10,000.00
Ending investment:	$11,597.00
Years:	0.21

Jasper Therapeutics Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Jasper Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding JSPR

JSPR — Current Quote

Quotes delayed 20 minutes

Free JSPR Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

JSPR — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Jasper Therapeutics Insider Buying occurred are:

Childrens Place Inc (The) Insider Buying
Sable Offshore Insider Buying
Radian Group Insider Buying
Oaktree Specialty Lending Insider Buying
Western New England Bancorp Insider Buying
Guaranty Bancshares Insider Buying
LTC Properties Insider Buying
Lakeland Bancorp Insider Buying
Rockwell Automation Insider Buying
Robinson (C.H.) Worldwide Insider Buying

Jasper Therapeutics Insider Buying

Jasper Therapeutics Insider Buying | www.HoldingsChannel.com